Fri, January 31, 2020

Brian Skorney Downgraded (VRTX) to Hold and Increased Target to $230 on, Jan 31st, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. nd-increased-target-to-230-on-jan-31st-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Brian Skorney of Baird, Downgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Hold and Increased Target from $210 to $230 on, Jan 31st, 2020.

Brian has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 0 agree with Brian's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Brian


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $265 on, Wednesday, January 8th, 2020
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $284 on, Monday, January 6th, 2020
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $229 on, Tuesday, November 19th, 2019
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019